Bank of America’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $118M | Sell |
1,452,277
-434,564
| -23% | -$31.4M | 0.01% | 1069 |
|
|
2026
Q1 | $129M | Buy |
1,886,841
+455,284
| +32% | +$32.2M | 0.01% | 956 |
|
|
2025
Q4 | $109M | Sell |
1,431,557
-85,479
| -6% | -$6.21M | 0.01% | 1054 |
|
|
2025
Q3 | $93.1M | Buy |
1,517,036
+135,628
| +10% | +$7.06M | 0.01% | 1255 |
|
|
2025
Q2 | $67.5M | Buy |
1,381,408
+865,281
| +168% | +$41.1M | ﹤0.01% | 1462 |
|
|
2025
Q1 | $26.3M | Buy |
516,127
+259,591
| +101% | +$13M | ﹤0.01% | 2166 |
|
|
2024
Q4 | $11.6M | Sell |
256,536
-58,187
| -18% | -$2.49M | ﹤0.01% | 2799 |
|
|
2024
Q3 | $11.7M | Buy |
314,723
+3,860
| +1% | +$129K | ﹤0.01% | 2921 |
|
|
2024
Q2 | $9.51M | Sell |
310,863
-72,834
| -19% | -$2.36M | ﹤0.01% | 2999 |
|
|
2024
Q1 | $11.2M | Buy |
383,697
+117,758
| +44% | +$3.3M | ﹤0.01% | 2886 |
|
|
2023
Q4 | $7.33M | Sell |
265,939
-113,229
| -30% | -$2.59M | ﹤0.01% | 3214 |
|
|
2023
Q3 | $8.5M | Sell |
379,168
-78,121
| -17% | -$2.91M | ﹤0.01% | 2885 |
|
|
2023
Q2 | $18.6M | Buy |
457,289
+10,925
| +2% | +$535K | ﹤0.01% | 2115 |
|
|
2023
Q1 | $21.6M | Buy |
446,364
+66,344
| +17% | +$3.03M | ﹤0.01% | 2047 |
|
|
2022
Q4 | $14.5M | Buy |
380,020
+40,457
| +12% | +$1.68M | ﹤0.01% | 2315 |
|
|
2022
Q3 | $17M | Sell |
339,563
-17,714
| -5% | -$868K | ﹤0.01% | 2101 |
|
|
2022
Q2 | $14.3M | Buy |
357,277
+71,482
| +25% | +$2.51M | ﹤0.01% | 2315 |
|
|
2022
Q1 | $10.7M | Sell |
285,795
-2,348,348
| -89% | -$90.5M | ﹤0.01% | 2803 |
|
|
2021
Q4 | $105M | Buy |
2,634,143
+2,352,106
| +834% | +$90M | 0.01% | 968 |
|
|
2021
Q3 | $10.5M | Sell |
282,037
-5,606
| -2% | -$230K | ﹤0.01% | 2800 |
|
|
2021
Q2 | $12.2M | Sell |
287,643
-75,067
| -21% | -$3.22M | ﹤0.01% | 2630 |
|
|
2021
Q1 | $17.2M | Buy |
362,710
+24,381
| +7% | +$1.45M | ﹤0.01% | 2173 |
|
|
2020
Q4 | $20.6M | Sell |
338,329
-60,457
| -15% | -$3.56M | ﹤0.01% | 1858 |
|
|
2020
Q3 | $18.6M | Buy |
398,786
+129,655
| +48% | +$6.38M | ﹤0.01% | 1763 |
|
|
2020
Q2 | $13.7M | Buy |
269,131
+32,901
| +14% | +$1.62M | ﹤0.01% | 1945 |
|
|
2020
Q1 | $10.5M | Buy |
236,230
+11,008
| +5% | +$554K | ﹤0.01% | 2023 |
|
|
2019
Q4 | $10.8M | Sell |
225,222
-43,282
| -16% | -$1.84M | ﹤0.01% | 2479 |
|
|
2019
Q3 | $9.08M | Sell |
268,504
-97,427
| -27% | -$4.24M | ﹤0.01% | 2606 |
|
|
2019
Q2 | $16.5M | Buy |
365,931
+90,386
| +33% | +$3.57M | ﹤0.01% | 2046 |
|
|
2019
Q1 | $10.4M | Buy |
275,545
+89,613
| +48% | +$3.01M | ﹤0.01% | 2450 |
|
|
2018
Q4 | $6.38M | Buy |
185,932
+11,878
| +7% | +$427K | ﹤0.01% | 2741 |
|
|
2018
Q3 | $8.18M | Sell |
174,054
-58,714
| -25% | -$2.43M | ﹤0.01% | 2688 |
|
|
2018
Q2 | $7.85M | Buy |
232,768
+35,017
| +18% | +$1.09M | ﹤0.01% | 2701 |
|
|
2018
Q1 | $5.35M | Sell |
197,751
-366,575
| -65% | -$9.29M | ﹤0.01% | 3017 |
|
|
2017
Q4 | $9.41M | Buy |
564,326
+181,192
| +47% | +$3.07M | ﹤0.01% | 2507 |
|
|
2017
Q3 | $7.67M | Sell |
383,134
-28,499
| -7% | -$558K | ﹤0.01% | 2775 |
|
|
2017
Q2 | $7.54M | Sell |
411,633
-65,489
| -14% | -$882K | ﹤0.01% | 2649 |
|
|
2017
Q1 | $4.7M | Sell |
477,122
-46,901
| -9% | -$568K | ﹤0.01% | 3091 |
|
|
2016
Q4 | $5.72M | Buy |
524,023
+30,083
| +6% | +$316K | ﹤0.01% | 2805 |
|
|
2016
Q3 | $6.92M | Sell |
493,940
-9,179
| -2% | -$74.6K | ﹤0.01% | 2550 |
|
|
2016
Q2 | $3.53M | Buy |
503,119
+186,125
| +59% | +$1.37M | ﹤0.01% | 3108 |
|
|
2016
Q1 | $2.04M | Buy |
316,994
+23,907
| +8% | +$415K | ﹤0.01% | 3545 |
|
|
2015
Q4 | $9.5M | Sell |
293,087
-3,903
| -1% | -$115K | ﹤0.01% | 2301 |
|
|
2015
Q3 | $7.93M | Buy |
296,990
+186,590
| +169% | +$7.98M | ﹤0.01% | 2427 |
|
|
2015
Q2 | $5.31M | Buy |
110,400
+73,065
| +196% | +$4.26M | ﹤0.01% | 2531 |
|
|
2015
Q1 | $2.27M | Buy |
37,335
+28,815
| +338% | +$1.76M | ﹤0.01% | 3136 |
|
|
2014
Q4 | $441K | Buy |
8,520
+2,227
| +35% | +$98K | ﹤0.01% | 4730 |
|
|
2014
Q3 | $277K | Sell |
6,293
-3,634
| -37% | -$114K | ﹤0.01% | 5087 |
|
|
2014
Q2 | $259K | Buy |
9,927
+9,905
| +45,023% | +$212K | ﹤0.01% | 5312 |
|
|
2014
Q1 | $1K | Sell |
22
-1,725
| -99% | -$46.4K | ﹤0.01% | 7640 |
|
|
2013
Q4 | $30K | Buy |
+1,747
| New | +$30.7K | ﹤0.01% | 6843 |
|
Other funds holding PTCT
RI
JT
Bank of America's PTCT Position: Q2 2026 in Review
Bank of America reduced its PTC Therapeutics (PTCT) stake by 23% in Q2 2026, selling an estimated $31.4M and leaving 1,452,277 shares worth $118M. The position accounts for 0.01% of the portfolio, ranked #1069.
Bank of America first reported a position in PTCT in Q4 2013 and has held it in 51 quarters since. The position peaked at $129M in Q1 2026. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Bank of America held 1,452,277 shares of PTC Therapeutics worth $118M as of Q2 2026.
- Bank of America sold 434,564 PTC Therapeutics shares in Q2 2026, an estimated $31.4M.
- PTC Therapeutics made up 0.01% of Bank of America's portfolio in Q2 2026, its #1069 holding.
- Bank of America first reported a position in PTC Therapeutics in Q4 2013 and has held it in 51 quarters since.
- Bank of America's PTC Therapeutics position peaked at $129M in Q1 2026.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.